We have become aware of an individual who is falsely representing themselves as a member of the Celerion HR team. Please be cautious when responding to any communication that purports to come from Celerion. All email communication from Celerion will come from an email address appended @celerion.com. No other addresses are legitimate. #hr
Celerion
Pharmaceutical Manufacturing
Lincoln, NE 14,610 followers
Celerion Can Take You from First-In-Human through Proof-of-Concept.
About us
Celerion, a leader in early clinical research, delivers Applied Translational Medicine. Celerion applies our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines. With over 50 years of experience and 600 global clinic beds (including 24 in-hospital), Celerion conducts and analyzes First-in-Human, clinical proof-of-concept, cardiovascular safety (TQT, robust QT), ADME and NDA-enabling clinical pharmacology studies. Celerion provides expertise on modeling and simulation, study design, medical writing (protocols and reports), clinical data sciences, biostatistics, and PK/PD analysis as well as small and large molecule bioanalytical assays through clinical drug development. Regulatory, drug development and program management complement Celerion’s service offerings. Our operations are strategically located in: Lincoln, Nebraska (Corporate Headquarters) Philadelphia, Pennsylvania Phoenix, Arizona Belfast, Northern Ireland,UK Zurich, Switzerland Vienna, Austria Richmond, Virginia Montreal, Quebec, Canada For more information, visit: www.celerion.com
- Website
-
http://www.celerion.com
External link for Celerion
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Lincoln, NE
- Type
- Privately Held
- Founded
- 2010
- Specialties
- Applied Translational Medicine, Global Clinical Research (Phase I and II, NDA-enabling clinical pharmacology), Data Management and Biometrics, Global Bioanalytical Services (discovery through late phase), Drug Development Services, and Global Clinical Development
Locations
Employees at Celerion
Updates
-
A DDI study is recommended to evaluate how an investigational drug interacts with other drugs through CYP enzymes and drug transporters by either being a substrate, an inhibitor, or an inducer. Also, a DDI study may be needed if the study drug is intended to be co-administered with other medications, such as combined oral contraceptives (COC) or acid-reducing agents (ARA). Learn about these unique study designs: https://lnkd.in/eUzpEvqm #DDIStudies #DrugInteractions #CYPEnzymes #PharmaResearch
-
Join us for a special talk on 5/29 at 11:15 am ET, hosted by AAPS, featuring Dr. Johannes Stanta, Ph.D., from Celerion. Discover groundbreaking developments in gene therapy through Dr. Stanta's presentation on vector shedding assays. Learn about a new sensitive method to detect AAV8 vector shedding in biological samples like blood, plasma, and more. Don't miss out on enhancing your understanding of these pivotal advancements! Enroll now: https://lnkd.in/dvq8iZ79 #GeneTherapy #Biotech #AAPS #HealthcareScience
-
Time is running out on WRIB! Don't miss your chance to connect with our team. Swing by booth #33 to explore how we can support your bioanalytical needs and accelerate your drug development program. We're excited to meet you! #WRIB2024 #ClinicalTrialsInnovation #BiomarkerResearch #GeneCellTherapy #SanAntonioEvents
-
A co-located Clinic and Bioanalytical lab allows for robust PBMC sample integrity, immediate sample analysis & saves on shipping costs. Learn more about what our site in Lincoln, NE has to offer: https://lnkd.in/eQ5f88Jb Learn more about our bioanalytical services: https://lnkd.in/g2B35hU2 #BioanalyticalInnovation #HealthcareEfficiency #LabLife #MedicalResearch
-
Welcome to the Lincoln team Jo!
We're excited to announce that Jo Goodman has joined Celerion as Vice President of Bioanalytical Services! With nearly three decades in pharmaceutical research, Jo brings a depth of expertise that will greatly enhance our capabilities at our Lincoln, Nebraska laboratory. Her leadership and experience is set to drive innovation and uphold our commitment to industry-leading science and fast delivery. Please join us in welcoming Jo to the Celerion family! Read the full press release: https://lnkd.in/et8afBSX #Celerion #BioanalyticalServices #Pharmaceuticals #NewBeginnings
-
Exciting News! The 15th Annual Outsourcing in Clinical Trials East Coast is set for May 21-22, 2024, in King of Prussia, PA. Mark your calendars for an enriching experience and join us there! Learn More: https://lnkd.in/esPtgp4V #OCTEastCoast #ClinicalTrials
-
This comprehensive tutorial describes the current regulatory framework for assessing TQT liability of a new chemical entity and serves as a practical guide for drug sponsors. Here, we address sponsor and regulatory considerations governing study design for ICH E14/S7B Q&A 5.1 and 6.1 substitution pathways in lieu of undertaking a dedicated TQT study. Read the CPT tutorial: https://lnkd.in/eeaVxPvT #TQTwaiver #TQTsubstitution #ECGcorelab
-
As Celerion is continuously looking to help improve treatment options for asthma, we’re proud we had the opportunity to support the clinical development of SinoMab’s asthma-targeting, biological lead SM17 by successfully completing their First-in-Human study (NCT05332834). Learn more: https://lnkd.in/d3uTtUdF #WorldAsthmaDay #AsthmaAwareness #BreatheEasy #AsthmaCare
-
We're excited to announce that Jo Goodman has joined Celerion as Vice President of Bioanalytical Services! With nearly three decades in pharmaceutical research, Jo brings a depth of expertise that will greatly enhance our capabilities at our Lincoln, Nebraska laboratory. Her leadership and experience is set to drive innovation and uphold our commitment to industry-leading science and fast delivery. Please join us in welcoming Jo to the Celerion family! Read the full press release: https://lnkd.in/et8afBSX #Celerion #BioanalyticalServices #Pharmaceuticals #NewBeginnings